Zum Inhalt der Seite gehen

Suche

Beiträge, die mit lp_8_1 getaggt sind


Here's the latest variant picture for Europe (excluding the UK), to early March.

The XEC.* variant remains dominant, but it has declined to around 31% frequency.

The LP.8.1.* variant grew to around 23%.

Note the recent sample volumes are very low, so this might not be a representative picture.

#COVID19 #EUR #XEC #LP_8_1
🧵


Here's the latest variant picture for the United States, to mid-March.

The LP.8.1.* variant has continued to grow steadily to around 49%.

The XEC.* variant continued to fall, down to around 19%.

#COVID19 #USA #XEC #LP_8_1
🧵


Here's the latest variant picture for Australia, to early March.

XEC.* continues to dominate, although fairly flat at around 50-60%.

The LP.8.1.* variant grew to around 18%, finally challenging the DeFLuQE variants as the new challenger.

#COVID19 #Australia #XEC #LP_8_1 @auscovid19
🧵


Here's the latest variant picture with a global scope, to mid- March.

The LP.8.1.* variant grew to around 38%, taking over dominance from the declining XEC.* variant.

#COVID19 #Global #XEC #LP_8_1
🧵


Here's the latest variant picture for the United Kingdom, to early March.

The XEC.* variant remains dominant, but it has fallen to around 44% frequency.

The LP.8.1.* variant grew somewhat to 21%, but then fell back in recent samples to finish at around 17%.

#COVID19 #UK #XEC #LP_8_1
🧵


Here's the latest variant picture for the United Kingdom.

The XEC.* variant remains dominant, but growth has stalled at around 60% frequency.

The LP.8.1.* variant grew somewhat to 19% frequency, but then fell back in recent samples to finish at around 15%.

#COVID19 #UK #XEC #LP_8_1
🧵


Here's the latest variant picture for the United States.

The XEC.* variant has been overtaken by the LP.8.1.* variant - growing steadily to around 34%.

There’s a rebound underway among the JN.1.* + FLiRT variants, led by the LB.1.3.1 lineage.

#COVID19 #USA #XEC #LP_8_1
🧵


Here's the latest variant picture for New Zealand.

DeFLuQE variants continue to dominate, with XEC.* struggling to break above 40%.

This quite an unusual picture as XEC.* is already dominant in most places.

The LP.8.1.* variant has mostly been below 10%.

#COVID19 #NZ #DeFLuQE #XEC #LP_8_1
🧵


Here's the latest variant picture with a global scope.

The XEC.* variant has continued to decline, while the LP.8.1.* variant grew to around 23%.

There seems to be a rebound in the JN.1.* + FLiRT family, rising recently to around 12%

#COVID19 #Global #XEC #LP_8_1
🧵


Here's the latest variant picture for the United States.

The XEC.* variant is still dominant, but looks like losing top spot shortly.

The LP.8.1.* variant has been growing steadily – up to around 31% and on track to take over from XEC.*.

#COVID19 #USA #XEC #LP_8_1
🧵


Here's the latest variant picture for the United Kingdom.

XEC.* remains dominant, but growth has stalled at around 70%.

The LP.8.1.* variants have grown to around 14% frequency.

#COVID19 #UK #XEC #LP_8_1
🧵


Here's the latest variant picture for the United Kingdom.

Growth of XEC.* continued, to around 76%.

The new LP.8.1.* variants are present, but have struggled to grow above 10% frequency. Globally, this group looks like the most likely challenger.

#COVID19 #UK #XEC #LP_8_1
🧵


Here's the latest variant picture for Europe (excluding the UK).

Growth of XEC.* continued, to around 55%.

The new LP.8.1.* variants are present, didn’t make the cut of the top 6. Globally, this group looks like the most likely challenger.

#COVID19 #EUR #XEC #LP_8_1
🧵


With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

The leading contenders at this point are LP.8.1 and XEC.4.

I show them here using a log scale, so you can compare their growth rates vs OG XEC.

#COVID19 #XEC #LP_8_1
🧵


With the XEC variant on the way to dominance in most places, and XEC waves starting to show in COVID metrics, it is time to ponder which variant will drive the next wave after XEC.

The leading contenders at this point are LP.8.1 and XEC.4.

They are shown here using a log scale, so you can compare their growth rates vs OG XEC.

#COVID19 #XEC #LP_8_1
🧵